Skip to main content
. 2024 Jan 9;65(1):23. doi: 10.1167/iovs.65.1.23

Table 1.

Demographics of 3390 SICCA Participants by SjD Status

Characteristic All (n = 3380) Non-SjD (n = 1848) SjD (n = 1532) Difference (95% CI) P Value
Age (years) 53.0 ± 13.2 53.6 ± 13.0 52.3 ± 13.4 −1.3 (−2.2 to −0.5) 0.003
Sex <0.001
 Female 3078 (91.1) 1646 (89.1) 1432 (93.5) 4.4% (2.5% to 6.3)
 Male 293 (8.7) 196 (10.6) 97 (6.3) −4.3% (−6.2% to −2.4%)
Region <0.001
 America 1687 (49.9) 1024 (55.4) 663 (43.3) −12.1% (−15.6% to −8.7%)
 Asia 805 (23.8) 278 (15.0) 527 (34.4) 19.4% (16.4% to 22.3%)
 Europe 888 (26.3) 546 (29.5) 342 (22.3) −7.2% (−10.2% to −4.2%)
Race/ethnicity <0.001
 Caucasian 1969 (58.3) 1248 (67.5) 721 (47.1) −20.5% (−23.8% to −17.1%)
 Asian or Pacific Islander 919 (27.2) 324 (17.5) 595 (38.8) 21.3% (18.3% to 24.4%)
 Hispanic/Latino 352 (10.4) 202 (10.9) 150 (9.8) −1.1% (−3.3% to 1.0%)
 African 93 (2.8) 47 (2.5) 46 (3.0) 0.5% (−0.7% to 1.6%)
 Native American 35 (1.0) 19 (1.0) 16 (1.0) 0.0% (−0.7% to 0.7%)
Education 0.003
 High school and lower 1378 (40.8) 701 (37.9) 677 (44.2) 6.3% (2.9% to 9.6%)
 College and above 2002 (59.2) 1147 (62.1) 855 (55.8) −6.3% (−9.6% to −2.9%)
Employment <0.001
 Not Working 547 (16.2) 362 (19.6) 185 (12.1) −7.5% (−10.0% to −5.0%)
 Working 2082 (61.6) 1063 (57.5) 1019 (66.5) 9.0% (5.7% to 12.3%)
 Retired 740 (21.9) 416 (22.5) 324 (21.1) −1.4% (−4.2% to 1.5%)
 Others 481 (14.2) 248 (13.6) 233 (14.8) 1.2% (−1.2% to 3.6%)
Smoking <0.001
 Never 1995 (59.0) 975 (52.8) 1020 (66.6) 13.8% (10.5% to 17.2%)
 Ever 1063 (31.4) 627 (33.9) 436 (28.5) −5.5% (−8.7% to −2.3%)
 Current 322 (9.5) 246 (13.3) 76 (5.0) −8.4% (−10.3% to −6.4%)
General health 0.004
 Poor 396 (11.7) 257 (13.9) 139 (9.1) −4.8% (−7.0% to −2.6%)
 Fair 1270 (37.6) 687 (37.2) 583 (38.1) 0.9% (−2.5% to 4.2%)
 Good 1149 (34.0) 596 (32.3) 553 (36.1) 3.8% (0.6% to 7.1%)
 Very Good 491 (14.5) 267 (14.4) 224 (14.6) 0.2% (−2.3% to 2.6%)
 Excellent 63 (1.9) 33 (1.8) 30 (2.0) 0.2% (−0.8% to 1.2%)
Ability to produce tears <0.001
 No 760 (22.5) 288 (15.6) 472 (30.8) 15.2% (12.3% to 18.1%)
 Yes 2603 (77.0) 1551 (83.9) 1052 (68.7) −15.3% (−18.2% to −12.3%)
Dry eye therapy
 Artificial tears 2140 (63.3) 1164 (63.0) 976 (63.7) 0.7% (−2.6% to 4.0%) >0.999
 Punctal occlusion 317 (9.4) 160 (8.7) 157 (10.2) 1.6% (−0.5% to 3.6%) >0.999
 Steroids 130 (3.8) 75 (4.1) 55 (3.6) −0.5% (−1.8% to 0.9%) >0.999
 Antibiotics 192 (5.7) 86 (4.7) 106 (6.9) 2.3% (0.6% to 3.9%) 0.047
 Cyclosporine 327 (9.7) 188 (10.2) 139 (9.1) −1.1% (−3.2% to 1.0%) >0.999
No. of dry eye therapies 1.000
 0 1134 (33.6) 641 (34.7) 493 (32.2) −2.5% (−5.8% to 0.7%)
 1 1600 (47.3) 861 (46.6) 739 (48.2) 1.6% (−1.8% to 5.1%)
 ≥2 646 (19.1) 346 (18.7) 300 (19.6) 0.9% (−1.9% to 3.6%)
Length of feeling eye dry (years) 3.91 (7.65) 3.73 (7.46) 4.16 (7.80) 0.43 (−0.09 to 0.93) 0.210

Values are mean ± SD, number (%), or median (IQR) unless otherwise noted.